Scientific Concept of the National Cohort (status ... - Nationale Kohorte

C.3
References
727. Ryu, O.H., et al., Identification of parotid salivary biomarkers in Sjogren's
syndrome by surface-enhanced laser desorption/ionization time-of-flight mass
spectrometry and two-dimensional difference gel electrophoresis. Rheumatology,
2006. 45(9): p. 1077.
728. Streckfus, C. and L. Bigler, The use of soluble, salivary c-erbB-2 for the
detection and post-operative follow-up of breast cancer in women: the results of a
five-year translational research study. Advances in Dental Research, 2005. 18(1):
p. 17.
729. Baker, P.I., D.R. Love, and L.R. Ferguson, Role of gut microbiota in Crohns
disease. Expert Review of Gastroenterology and Hepatology, 2009. 3(5): p. 535-
546.
730. Isolauri, E., et al., Obesity–Extending the Hygiene Hypothesis. Microbial hostinteraction:
tolerance versus allergy, 2009: p. 75.
731. Possemiers, S., et al., The intestinal environment in health and disease-recent
insights on the potential of intestinal bacteria to influence human health. Current
Pharmaceutical Design, 2009. 15(18): p. 2051-2065.
732. Musso, G., R. Gambino, and M. Cassader, Gut microbiota as a regulator of
energy homeostasis and ectopic fat deposition: mechanisms and implications for
metabolic disorders. Current opinion in lipidology, 2010. 21(1): p. 76.
733. Musso, G., R. Gambino, and M. Cassader, Obesity, Diabetes, and Gut
Microbiota. Diabetes care, 2010. 33(10): p. 2277.
734. Andoh, A., et al., Recent advances in molecular approaches to gut microbiota in
inflammatory bowel disease. Current Pharmaceutical Design, 2009. 15(18): p.
2066-2073.
735. Jansson, J., et al., Metabolomics reveals metabolic biomarkers of Crohn's
disease. PloS one, 2009. 4(7): p. e6386.
736. Tuohy, K.M., et al., Studying the human gut microbiota in the trans-omics erafocus
on metagenomics and metabonomics. Current Pharmaceutical Design,
2009. 15(13): p. 1415-1427.
737. Williams, H.R.T., et al., Characterization of inflammatory bowel disease with
urinary metabolic profiling. The American journal of gastroenterology, 2009.
104(6): p. 1435-1444.
738. Jia, W., et al., Gut microbiota: a potential new territory for drug targeting. Nature
Reviews Drug Discovery, 2008. 7(2): p. 123-129.
739. Wos-Oxley, M., et al., A poke into the diversity and associations within human
anterior nare microbial communities. The ISME Journal, 2010. 4(7): p. 839-851.
740. Rathmann, W., et al., Hemoglobin A1c and glucose criteria identify different
subjects as having type 2 diabetes in middle-aged and older populations: The
KORA S4/F4 Study. Annals of Medicine, 2010(0): p. 1-8.
741. Tiller, D., Kluttig A, B Schumann B, Werdan K, Haerting J, Greiser K.,
Response der CARLA-Follow-up Untersuchung (2007-2010). Gesundheitswesen,
2010. 72.
742. Frost, C. and I.R. White, The effect of measurement error in risk factors that
change over time in cohort studies: do simple methods overcorrect for'regression
dilution'? International journal of epidemiology, 2005. 34(6): p. 1359.
330